Citation: S. Mathas et al., ANTI-CD20 ANTIBODY IDEC-C2B8 MEDIATED APOPTOSIS CAN BE BLOCKED BY INHIBITION OF CASPASE-3, Experimental hematology, 26(8), 1998, pp. 161-161
Authors:
OTTO A
MULLER EC
BROCKSTEDT E
SCHUMANN M
RICKERS A
BOMMERT K
WITTMANNLIEBOLD B
Citation: A. Otto et al., HIGH-PERFORMANCE 2-DIMENSIONAL GEL-ELECTROPHORESIS AND NANOELECTROSPRAY MASS-SPECTROMETRY AS POWERFUL TOOL TO STUDY APOPTOSIS-ASSOCIATED PROCESSES IN A BURKITT-LYMPHOMA CELL-LINE, Journal of protein chemistry, 17(6), 1998, pp. 564-565
Authors:
BROCKSTEDT E
RICKERS A
KOSTKA S
LAUBERSHEIMER A
DORKEN B
WITTMANNLIEBOLD B
BOMMERT K
OTTO A
Citation: E. Brockstedt et al., IDENTIFICATION OF APOPTOSIS-ASSOCIATED PROTEINS IN A HUMAN BURKITT-LYMPHOMA CELL-LINE - CLEAVAGE OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINA1 BY CASPASE-3, The Journal of biological chemistry, 273(43), 1998, pp. 28057-28064
Authors:
RICKERS A
BROCKSTEDT E
MAPARA MY
OTTO A
DORKEN B
BOMMERT K
Citation: A. Rickers et al., INHIBITION OF CPP32 BLOCKS SURFACE IGM-MEDIATED APOPTOSIS AND D4-GDI CLEAVAGE IN HUMAN BL60 BURKITT-LYMPHOMA CELLS (VOL 28, PG 296, 1998), European Journal of Immunology, 28(3), 1998, pp. 1122-1122
Authors:
RICKERS A
BROCKSTEDT E
MAPARA MY
OTTO A
DORKEN B
BOMMERT K
Citation: A. Rickers et al., INHIBITION OF CPP32 BLOCKS SURFACE IGM-MEDIATED APOPTOSIS AND D4-GDI CLEAVAGE IN HUMAN BL60 BURKITT-LYMPHOMA CELLS, European Journal of Immunology, 28(1), 1998, pp. 296-304
Authors:
BARGOU RC
JURCHOTT K
WAGENER C
BERGMANN S
METZNER S
BOMMERT K
MAPARA MY
WINZER KJ
DIETEL M
DORKEN B
ROYER HD
Citation: Rc. Bargou et al., NUCLEAR-LOCALIZATION AND INCREASED LEVELS OF TRANSCRIPTION FACTOR YB-1 IN PRIMARY HUMAN BREAST CANCERS ARE ASSOCIATED WITH INTRINSIC MDR1 GENE-EXPRESSION, Nature medicine, 3(4), 1997, pp. 447-450
Authors:
EMMERICH F
BARGOU RC
KRAPPMANN D
BOMMERT K
SCHEIDEREIT C
DORKEN B
Citation: F. Emmerich et al., NF KAPPA-B ACTIVATION REQUIRED FOR PROLIFERATION AND APOPTOSIS-RESISTANCE OF HODGKINS-DISEASE TUMOR-CELLS, Experimental hematology, 25(8), 1997, pp. 91-91
Authors:
BARGOU RC
EMMERICH F
KRAPPMANN D
BOMMERT K
MAPARA MY
ARNOLD W
ROYER HD
GRINSTEIN E
GREINER A
SCHEIDEREIT C
DORKEN B
Citation: Rc. Bargou et al., CONSTITUTIVE NUCLEAR FACTOR-KAPPA-B-RELA ACTIVATION IS REQUIRED FOR PROLIFERATION AND SURVIVAL OF HODGKINS-DISEASE TUMOR-CELLS, The Journal of clinical investigation, 100(12), 1997, pp. 2961-2969
Authors:
WEINMANN P
BOMMERT K
MAPARA MY
DORKEN B
BARGOU RC
Citation: P. Weinmann et al., OVEREXPRESSION OF THE DEATH-PROMOTING GENE BAX-ALPHA SENSITIZES HUMANBL-41 BURKITT-LYMPHOMA CELLS FOR SURFACE IGM-MEDIATED APOPTOSIS, European Journal of Immunology, 27(9), 1997, pp. 2466-2468
Authors:
DANIEL PT
OETTINGER U
MAPARA MY
BOMMERT K
BARGOU R
DORKEN B
Citation: Pt. Daniel et al., ACTIVATION AND ACTIVATION-INDUCED DEATH OF HUMAN TONSILLAR B-CELLS AND BURKITT-LYMPHOMA CELLS - LACK OF CD95 (FAS APO-1) LIGAND EXPRESSION AND FUNCTION/, European Journal of Immunology, 27(4), 1997, pp. 1029-1034
Citation: K. Bommert et al., INHIBITION OF CPP32 BLOCKS SURFACE IGM-MEDIATED APOPTOSIS AND D4-GDI CLEAVAGE IN HUMAN BL6O BURKITT-LYMPHOMA CELLS, Blood, 90(10), 1997, pp. 1395-1395
Authors:
EMMERICH F
BARGOU RC
KRAPPMANN D
BOMMERT K
GREINER A
SCHEIDEREIT C
DORKEN B
Citation: F. Emmerich et al., NF-KAPPA-B ACTIVATION REQUIRED FOR PROLIFERATION AND APOPTOSIS-RESISTANCE OF HODGKINS-DISEASE TUMOR-CELLS, Blood, 90(10), 1997, pp. 1729-1729
Authors:
BARGOU RC
WAGENER C
BOMMERT K
ARNOLD W
DANIEL PT
MAPARA MY
GRINSTEIN E
ROYER HD
DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF TRANSCRIPTION FACTOR E2F DP BY DOMINANT-NEGATIVE MUTANTS IN A NORMAL BREAST EPITHELIAL-CELL LINE EFFICIENTLY INHIBITS APOPTOSISAND INDUCES TUMOR-GROWTH IN SCID MICE/, The Journal of experimental medicine, 183(3), 1996, pp. 1205-1213
Authors:
WAGENER C
BARGOU RC
DANIEL PT
BOMMERT K
MAPARA MY
ROYER HD
DORKEN B
Citation: C. Wagener et al., INDUCTION OF THE DEATH-PROMOTING GENE BAX-ALPHA SENSITIZES CULTURED BREAST-CANCER CELLS TO DRUG-INDUCED APOPTOSIS, International journal of cancer, 67(1), 1996, pp. 138-141
Citation: K. Bommert et al., IDENTIFICATION OF CELL-DEATH ASSOCIATED GENES AFTER INDUCTION OF APOPTOSIS BY SURFACE IGM CROSS-LINKING IN THE HUMAN BURKITT-LYMPHOMA CELL-LINE BL41, Blood, 88(10), 1996, pp. 3450-3450
Authors:
DANIEL PT
HEMPEL C
BOMMERT K
BARGOU RC
MAPARA MY
DORKEN B
Citation: Pt. Daniel et al., TRIGGERING OF THE B-CELL ANTIGEN RECEPTOR PREVENTS CD95 (APO-1 FAS) MEDIATED APOPTOSIS OF CD40 LIGAND-ACTIVATED B-CELLS/, Blood, 88(10), 1996, pp. 640-640
Authors:
BARGOU RC
EMMERICH F
KRAPPMANN D
BOMMERT K
MAPARA MY
ARNOLD W
ROYER HD
SCHEIDEREIT C
DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF NF-KAPPA-B BY DOMINANT-NEGATIVE IKB-ALPHA MUTANT IN THE HODGKIN CELL-LINE HD-MYZ REDUCES CELL-CYCLE PROGRESSION, PROMOTES APOPTOSIS AND SUPPRESSES TUMOR-GROWTH IN SCID MICE, Blood, 88(10), 1996, pp. 1527-1527
Authors:
BARGOU RC
LENG C
KRAPPMANN D
EMMERICH F
MAPARA MY
BOMMERT K
ROYER HD
SCHEIDEREIT C
DORKEN B
Citation: Rc. Bargou et al., HIGH-LEVEL NUCLEAR NF-KAPPA-B AND OCT-2 IS A COMMON FEATURE OF CULTURED HODGKIN REED-STERNBERG CELLS/, Blood, 87(10), 1996, pp. 4340-4347
Authors:
BARGOU RC
BOMMERT K
MAPARA MY
DANIEL PT
DORKEN B
Citation: Rc. Bargou et al., CONSTITUTIVE NUCLEAR-BINDING ACTIVITY OF NF-KAPPA-B AND OCT-2 ARE A COMMON AND SPECIFIC FEATURE OF CULTURED AND PRIMARY HODGKIN CELLS, Experimental hematology, 23(8), 1995, pp. 780-780
Authors:
DANIEL PT
MAPARA MY
BOMMERT K
BARGOU RC
KRAMMER P
DORKEN B
Citation: Pt. Daniel et al., CD95 (APO-1 FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS/, Experimental hematology, 23(8), 1995, pp. 831-831
Authors:
BARGOU RC
BOMMERT K
MAPARA MY
DANIEL PT
DORKEN B
Citation: Rc. Bargou et al., SEQUENTIAL INDUCTION OF THE TRANSCRIPTION FACTOR NAK-1 AND BAX-ALPHA PRECEDES APOPTOSIS IN HUMAN BURKITT-LYMPHOMA, Experimental hematology, 23(8), 1995, pp. 889-889
Authors:
DANIEL PT
PANKOW RW
MAPARA MY
BOMMERT K
BARGOU RC
DORKEN B
Citation: Pt. Daniel et al., NAK-1, THE HUMAN NUR77 HOMOLOG, AND THE CD95 ANTIGEN (APO-1 FAS) ARE SEQUENTIALLY INVOLVED IN NORMAL AND MALIGNANT T-CELL APOPTOSIS/, Experimental hematology, 23(8), 1995, pp. 890-890